Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy
Clinical trial NCT04888507 · COMPLETED
Trial details
- NCT number
- NCT04888507
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2022-05-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.